Smart insulin pump aims to simplify diabetes management
NCT ID NCT07039981
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 27 times
Summary
This study tests a new automated insulin delivery system in 48 adults with type 2 diabetes aged 16–70. The system uses a smart algorithm to adjust insulin automatically, aiming to keep blood sugar in a safe range and reduce dangerous highs and lows. Participants use a study-provided insulin pump and continuous glucose monitor. The goal is to see if the technology is safe and effective for daily diabetes management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Otago, Christchurch
Christchurch, 8011, New Zealand
-
Wellington Regional Hospital
Wellington, 6021, New Zealand
Conditions
Explore the condition pages connected to this study.